Last reviewed · How we verify

NCT06970938

Cardiac Rehabilitation After Coronary Artery Bypass Graft Surgery

Completed NA Last updated 14 May 2025
What this trial tests

NA trial testing Cardiac rehabilitation program in Cardiac Rehabilitation in 28 participants. Completed in 29 April 2025.

Timeline
1 January 2025
Primary endpoint
29 April 2025
29 April 2025

Quick facts

Lead sponsorMuhammed Onur Hanedan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment28
Start date1 January 2025
Primary completion29 April 2025
Estimated completion29 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Muhammed Onur Hanedan

Who can join

18 and older, any sex, with Cardiac Rehabilitation or Coronary Artery Bypass Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the effects of cardiac rehabilitation program after CABG surgery on quality of life, sleep quality, anxiety, depression and cardiopulmonary functions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cardiac rehabilitation program

Trials testing the same drug.

Other recruiting trials for Cardiac Rehabilitation

Currently open trials in the same condition.

Other Muhammed Onur Hanedan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06970938.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing